Navigation Links
IFHP Study Reveals Disparity In Medical Costs Around The Globe
Date:3/26/2013

NEW YORK, March 26, 2013 /PRNewswire/ -- The International Federation of Health Plans today released its 2012 Comparative Price Report, detailing its annual survey of medical costs per unit. Designed to showcase the variation in healthcare costs around the world, the report examines the price of medical procedures, tests, scans and treatments in 12 countries, as well as the costs of six widely-prescribed drugs. The survey data showed that the United States continues to have the highest prices of those countries surveyed for both medical procedures and drugs.

For example, the average cost for a hospital day is $429 in Argentina, $665 in South Africa and an average of $4,287 in the U.S. A diagnostic procedure such as a colonoscopy will cost from an average of $413 in Argentina to $893 in the United Kingdom and $1,185 in the United States. The survey also found that the cost of a widely prescribed drug for depression, Cymbalta, can range from $47 in the France to $176, the average cost in the U.S.

As in prior surveys, the differential between unit prices was greatest for surgical procedures. One of the highest differentials was for C-sections: The range ran from $1,541 in Argentina to an average of $15,041 in the United States.

IFHP will host a conference call and Webinar with Chief Executive Tom Sackville at 10 a.m. PDT / 1 p.m. EDT on Tues., March 26, to discuss the findings. Details for joining the conference call and Webinar follow at the end of this news release.

"With the cost and availability of healthcare being an important topic around the world, it's essential that we not only examine the disparities that exist, but also why and how certain gaps do exist," said IFHP's Sackville.

Costs examined in the study included those from Argentina, Australia, Canada, Chile, France, Germany, India, New Zealand, South Africa, Spain, Switzerland and the United States. The data for the report was gathered from IFHP member organizations in each country.  

The IFHP was founded in 1968 by a group of health fund industry leaders, and is now the leading global network of the industry, with nearly 100 member companies across 25 countries. IFHP aims to assist in the maintenance of high ethical and professional standards throughout the industry. 

For a copy of the report and more information about IFHP, please visit www.ifhp.com.

Following are details for the conference call and Webinar to discuss the report findings:WHO:Tom Sackville, CEO of IFHPWHEN: 

Tuesday, March 2610 a.m. PDT/ 1 p.m. EDTWHERE: 

Remarks and Q&A session via conference call at (866) 901-4714 (U.S. and Canadian callers)(702) 599-4277 (callers outside United States and Canada)Conference ID: 26726254See the presentation online at: 

https://www.livemeeting.com/cc/edelman/join?id=FFMMB2&role=attend&pw=T%2F%7E5dhp
Meeting ID: FFMMB2
Entry Code: T/~5dhp

First Time Users:
To save time before the meeting, check your system to make sure it is ready to use Microsoft Office Live Meeting.

Troubleshooting
Unable to join the meeting? Follow these steps:

1.

Copy this address and paste it into your web browser: https://www.livemeeting.com/cc/edelman/join 2.

Copy and paste the required information: Meeting ID: FFMMB2Entry Code: T/~5dhpLocation: https://www.livemeeting.com/cc/edelman


'/>"/>
SOURCE International Federation of Health Plans
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. Study Finds Utilizing Integrated Medical and Pharmacy Data Improves Ability to Forecast Use of High-cost Specialty Treatments
2. Study Showed Patients Treated With The miraDry© System Experienced 82 Percent Sweat Reduction On Average
3. Asubio Initiates Landmark Clinical Study in Spinal Cord Injury
4. New Veridex Alliance Drives Study Of Circulating Tumor Cells In Men With Metastatic Prostate Cancer
5. Shingles Vaccine is Safe, According to New Study
6. Structural Trends to Profoundly Change Life Sciences Industry, Genpact Study Shows
7. Argos Therapeutics Secures $25 million Series D Financing to Commence Phase 3 ADAPT Study in Patients with Metastatic Renal Cell Carcinoma (mRCC) in Mid-2012
8. Anthera Announces the Completion of Patient Dosing in Phase 2b PEARL-SC Study
9. Omthera Pharmaceuticals Announces Positive Top-Line Results from Phase 3 EVOLVE Study
10. Accuray Launches First Study to Compare CyberKnife® SBRT to Surgery and IMRT for Treatment of Early-Stage Prostate Cancer
11. Interim results of VITOBA™ (VImpaT® added to One Baseline AED) Study Presented at the 64th Annual Meeting of the American Academy of Neurology
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/24/2017)... , Australien, 24. Februar 2017 ITL ... Unternehmen des Gesundheitsbereiches, ist erfreut, für das zum ... dem entsprechenden Vorjahreszeitraum exzellente Ergebnisse vorlegen zu können. ... Aktualisierung zum Wachstum" finden Sie hier . ... Gewinn nach Steuern 2,12 Millionen USD (Dez. 2015: 1,04 Millionen USD; +104 %) ...
(Date:2/24/2017)... 2017  Directors from Pharma To Market Pty Ltd and Ador ... resulting in the founding of Pharma To Market Pte Ltd, based ... are pleased to announce their expansion into Asia ... . The company are delighted to appoint Joelle Chia ... Singapore based entity. Joelle brings with her an ...
(Date:2/24/2017)... 2017 Non-alcoholic steatohepataitis (NASH) Pipeline ... drugs being developed for the treatment of ... that are in various phases of development ... on novel pharmacologic drugs & regenerative medicines ... recombinant proteins and RNA-based therapeutics, but excludes ...
Breaking Medicine Technology:
(Date:2/26/2017)... ... February 26, 2017 , ... NuevaCare, a leading home ... as Millbrae, Belmont, and Palo Alto, is proud to announce an important upgrade to ... consumers look for home care close to home, and by having city-specific pages, NuevaCare ...
(Date:2/26/2017)... ... , ... ODH, Inc.™ announced today it will exhibit and speak at ... Hotel in Arlington, VA. ODH’s director of medical strategy, Candace Saldarini, M.D., will present ... population health management. , ODH will also have an exhibit booth where attendees may ...
(Date:2/24/2017)... ... February 24, 2017 , ... ... TaskMate Go. Core benefits and advantages built into the home office sit stand ... look and feel. Ability to gain the benefits embedded in the TaskMate Go ...
(Date:2/24/2017)... ... February 24, 2017 , ... An in-depth computational analysis of genetic variants implicated ... to eight genes that may explain why susceptibility to one of the disorders could ... study published today in the journal npj Schizophrenia. , “There is a wealth ...
(Date:2/24/2017)... ... ... With millions of Americans and people worldwide struggling with ... aware of our options and are empowered with strength and information throughout the ... newest edition of "Vision and Hearing" in USA Today, that will educate readers ...
Breaking Medicine News(10 mins):